Related Experiment Video
Updated: Jan 12, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Impact of Animal-Assisted Interactions on Quality of Life in Children With Relapsed/Refractory Cancer and Their
Anne Ingalls Gillespie1, Brittany A Cowfer2,3, Mary S Dietrich4
1College of Nursing, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA.
Abstract:
BackgroundChildren with cancer are at increased risk for cognitive and physical suffering from side effects of treatment and disease sequelae. Animal-assisted interactions (AAIs) with canine therapy show strong promise to improve physical and psychosocial outcomes for children newly diagnosed with cancer. Few rigorous studies have focused on the role of AAI for children with relapsed/refractory cancer. The purpose of this study was to evaluate the preliminary efficacy of a randomized controlled trial (RCT) using AAI with children diagnosed with relapsed/refractory cancer for the outcome of health-related quality of life (HRQoL).MethodThis study was a component of a larger mixed-methods RCT in which 30 children (ages 3-17 years) with relapsed/refractory cancer and their caregivers were randomized to receive weekly AAI sessions with a dog and handler or usual care (UC) for 12 weeks during each child's visit to a hospital-based pediatric cancer center.ResultsMother and child dyads (N = 21) completed the PedsQL 3.0 Cancer Module at both baseline and 12 weeks (nine UC, 12 AAI) required for analyses. None of the changes over time were statistically significant (p > .05); the strongest effects were observed on communication and procedural anxiety.DiscussionWhile results were not statistically significant, they suggest AAI demonstrates potential for enhanced HRQoL for children with relapsed/refractory cancer. More research is needed with larger samples and may necessitate the use of a measure designed to capture issues particularly relevant to children with advanced disease.
Related Concept Videos
Treatment Resistant Cancers
Bioavailability Study Design: Healthy Subjects Versus Patients
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...